Systems solutions by lactic acid bacteria: from paradigms to practice by Vos, W.M., de
PROCEEDINGS Open Access
Systems solutions by lactic acid bacteria:
from paradigms to practice
Willem M de Vos
From 10th Symposium on Lactic Acid Bacterium
Egmond aan Zee, the Netherlands. 28 August - 1 September 2011
Abstract
Lactic acid bacteria are among the powerhouses of the food industry, colonize the surfaces of plants and animals, and
contribute to our health and well-being. The genomic characterization of LAB has rocketed and presently over 100
complete or nearly complete genomes are available, many of which serve as scientific paradigms. Moreover, functional
and comparative metagenomic studies are taking off and provide a wealth of insight in the activity of lactic acid
bacteria used in a variety of applications, ranging from starters in complex fermentations to their marketing as
probiotics. In this new era of high throughput analysis, biology has become big science. Hence, there is a need to
systematically store the generated information, apply this in an intelligent way, and provide modalities for constructing
self-learning systems that can be used for future improvements. This review addresses these systems solutions with a
state of the art overview of the present paradigms that relate to the use of lactic acid bacteria in industrial applications.
Moreover, an outlook is presented of the future developments that include the transition into practice as well as the
use of lactic acid bacteria in synthetic biology and other next generation applications.
Introduction
The historic use of bacteria that produce lactic acid and
collectively are designated lactic acid bacteria (LAB) is
well documented for a variety of food fermentations,
some even dating back to the earliest written records.
However, less exposed is the impact of LAB in the diet
of our far-away ancestors that lived over a million of
years ago. There is considerable support for the hypoth-
esis that lactobacilli and other notably plant-related LAB
have been consumed in large amounts in neolithic times
[1]. This so called paleo-diet may have contained over a
million more microbes than our present foods, resulting
in a high and continuous load of LAB. In retrospect,
this provides an explanation why some LAB have devel-
oped intimate interactions with our body and several
LAB are successfully marketed as probiotics [2,3].
Traditionally LAB have been considered to include low
G+C content Gram-positive bacteria included in the
phylum Firmicutes that are used as starters for industrial
food fermentations, notably those based on raw materials
derived from milk, meat and plants. These fermentations
together with probiotic products represent a total global
market value of over 100 Billion Euro (Table 1) [3,4].
Economically by far the most important products derive
from industrial dairy fermentations and include cheese,
yoghurt and other fresh dairy produce. These fermenta-
tions are initiated by well-known genera of LAB that
include Lactobacillus, Lactococcus and Streptococcus.
However, the market for probiotic bacteria in foods and
supplements is the most rapidly growing segment in the
fast moving consumer goods and expected to grow by 10
% each year [3]. Most of the applied probiotic bacteria
are Lactobacillus spp. However, approximately one third
are Bifidobacteria, a group of bacteria with a high G+C
content included in the phylum Actinobacteria that also
produce lactic acid but always in combination with acetic
acid. Bifidobacteria are almost exclusively found in asso-
ciation with animal hosts [5]. Hence, it is no surprise that
some Bifidobacterium strains are also marketed as pro-
biotic bacteria [2,3]. As various reviews on the genomics
and metabolism of Bifidobacteria have been reported
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recently [5-7], specific attention for this group is not in
the remit of this paper that will focus on the true LAB.
At the time that we are celebrating the 30 year anniver-
sary of the LAB symposia with the present LAB10, it is
appropriate to reflect and benchmark the position where
the science in this area has led us. Even more important
is the possibility to look ahead and present some future
perspectives in this area. This is done here with a focus
on the practical impact of the paradigm bacteria that
underpin a multibillion Euro industry (Table 1). More-
over, this is guided by the three major developments that
have brought the research on these powerhouses of the
probiotic and dairy industry at the level that it has now.
The first is the genomic revolution that has been quickly
implemented in LAB with the sequence analysis of pla-
mids, bacteriophages, and now genomes or collections of
genomes (Fig. 1). The second is the high throughput
experimentation that has become available and shown to
be of particular use for LAB. The final development
relates to the systems and synthetic biology approaches.
These systems solutions integrate all aspects of the meta-
bolism, genetics and application of LAB that have been
the leading theme of the past LAB symposia leading to
the present LAB10.
Paradigm genetic elements – early industrial
impact
An important part of the research on LAB is character-
ized by a strong focus on molecular biology and genetics.
This reflects the attention for this discipline originating
with the development of biotechnology. However,
another relevant factor contributing to the attention
for the genetics of LAB is the large impact of genetic ele-
ments, such as plasmids and bacteriophages. It appeared
from the pioneering work of Larry L. McKay that lacto-
cocci, then known as lactic streptococci, harbor large
plasmid complements and code for important functions
[8]. Many of these plasmids and bacteriophages have
been characterized at the sequence level and deposited in
the NCBI database accounting for a large genomic collec-
tion in the early nineties (Fig. 1). However, even prior to
this time, when deposition was not common, many
lactococcal plasmids have been sequenced, starting more
than 25 years ago with the 2.2 kb pSH71 replicon [9,10].
Many mobile elements that also include conjugative
transposons were found to encode important industrial
characteristics such as lactose and citrate metabolism,
proteinase, bacteriocin and exopolysaccharide (EPS) pro-
duction, as well as bacteriophage insensitivity. The early
discoveries that originate from a basic characterization of
their molecular properties have resulted in a variety of
applications and these paradigms are summarized here
(Table 2).
Among the most important applications with significant
industrial impact has been the stacking of genetic elements
in starter cultures that has been exploited to great extent
to increase bacteriophage resistance. As the improved
strains are obtained via natural conjugation systems, no
genetically modified organisms (GMOs) are generated,
and hence this has become one of the hallmarks of indus-
trial strain improvement of LAB [21,22,38]. The number
of bacteriophage insensitivity systems is ever increasing
and these continue to generate practically useful strains,
specifically for the dairy practice where an enormous load
of bacteriophage is encountered. Similarly, conjugative
transposons encoding metabolic properties, such as the
sucrose-nisin transposon and derivatives have been discov-
ered [24]. These have been exploited for generating non-
GMO starter strains that produce nisin and hence reduce
contaminating Listeria and other pathogens [39]. More-
over, new genetic elements continue to be discovered by
comparative and functional genomics approaches. These
include the conjugative maltose transposon detected in a
plant-derived strain of Lactococcus lactis and transferable
to model strains of Lactococcus lactis[40]. In addition,
genetic islands have been discovered and found to encode
the production of mucus-binding pili in the probiotic
Lactobacillus rhamnosus GG [31]. Finally, a highly impor-
tant system that protects prokaryotes from invasion by
foreign DNA such as bacteriophages and plasmids, is the
CRISPR system that has been discovered in Streptococcus
thermophilus[32-34]. About half of the bacteria contain
this CRISPR system and this also applies to the LAB
where, for instance, it is absent in Lactobacillus plantarum
and hence it can be considered as a specific genetic ele-
ment. The CRISP system forms a nucleic acid based
immunity system requiring the action of the specific endo-
nuclease activity of the CRISPR-associated Cascade com-
plex that recently has been worked out in detail [41]. The
CRISPR sequences are identical to parts of the bacterioph-
age genomes to which the strains are immune and hence
they have significant diagnostic value as they are indicative
of the bacteriophage history [34]. Moreover, the CRISPR-
system forms an important basis for the rational produc-
tion of bacteriophage-insensitive mutants that are essential
for successful industrial fermentations. It was observed
Table 1 Economic value of fermentations including LAB
and Bifidobacteria. Data taken from recent market
reviews and estimations [3,4]
Product Global Market Value
(Euro)
Main Bacterial Genera
Cheese Products 55 Billion Lactococcus
&Lactobacillus
Yoghurt & Fresh
Dairy
25 Billion Streptococcus
&Lactobacillus
Probiotic Products 20 Billion Lactobacillus
&Bifidobacterium
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that the Cascade system can be functionally transferred
[42]. This opens avenues for its further exploitation in
LAB that do not contain it naturally.
Several of the plasmid replicons such as that from the
related plasmids pSH71 and pWV01, have been studied
extensively and formed the basis for optimizing host-
vector and transformation systems [10,11,43]. It is of
interest to note that many of the gene cloning, expres-
sion and secretion systems developed more than 25
years ago [at the time that lactococci were still known
as streptococci], are still in use today in only slightly
modified form [9,11]. This also holds for food-grade
cloning and expression systems that were developed
based on extensive molecular characterization of the
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Figure 1 Development of genome sequencing in the last two decades. The number of entries in the NCBI database were scored and summed
for the plasmids and bacteriophages [phages] as well as the genomes from Lactobacillus or Lactococcus and Streptrococcus spp. that are
considered as LAB.
Table 2 Paradigms of the mobile and other genetic elements in LAB
Function Paradigm Element [Genes] Discovery or Exploitations References
Replication pWV01/pSH71 [repAB] Plasmid Vectors and Copy Number [9-11]
Lactose Metabolism pLP712 [lacFEG] Controlled Expression; Food Grade Markers [12-14]
High Frequency Conjugation pLP712 [cluA] Clumping and High Frequency Conjugal Transfer [15]
Proteinase Production pWV05 – pSK112 [prtPM] Chaperon Function; Flavor Engineering [16-18]
Citrate Metabolism pCT176 [citP] Citrate Transport; Flavor Engineering [19]
Bacteriophage Resistance pTR2030 [abiA-abiZ] Bacteriophage Resistant Starters [20-22]
Nisin and Phage Resistance pNP40 Bacteriophage Resistance Starters [23]
Sucrose-Nisin Transposon Tn5276 [sac &nis operons] Conjugal Transfer; Antimicrobial Strains; NICE system] [24,26]
EPS Production pNZ4000 [eps operon] EPS Priming Polymerase; Structure Engineering [27]
Temperate Phage Bacteriophage r1t Temperature Controlled Expression [28-30]
Mucus Binding GGISL2 [spaCBA-srtA] Genomic Island for Mucus Binding Pili [31]
Phage and Plasmid Resistance CRISPR-cas operon Bacteriophage & Plasmid Immunity System [32-34]
Production of SLP SLP Phase Variation and SLP Induced DC SIGN signalling [35-37]
The canonical functions of the elements are provided with its genetic designation and, if appropriate, the relevant genes. Moreover, the potential impact of
elements is indicated with key references. The elements include plasmids, transposons, genomic islands, gene cassettes or other discrete genomic sequences.
NICE: Nisin Inducible Controlled Expression, SLP; Surface Layer Protein.
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lactococcal lactose metabolism [12,14]. Moreover,
detailed analysis of the nisin biosynthetic pathway led to
the discovery of peptide-mediated communication mod-
ules [25]. These formed the basis for the Nisin Induced
Controlled Expression (NICE) systems that are used
worldwide for controlled gene expression [26,44]. The
utility of this system was demonstrated in dozens of stu-
dies [45]. An important spin off was the development of
controlled lysis in cheese starters that may contribute to
accelerated cheese ripening [46]. Similarly, the genomic
characterization of the first complete lactococcal bacter-
iophage resulted in the development of a controlled
expression system based on its regulatory circuit [29,30].
Paradigm strains of LAB – from genetic models to
application
Given the interest and developments in the LAB genetics
it is no surprise that genomics approaches were embraced
in the early days (Fig. 1). As complete genome sequencing
was relative slow and notably expensive, there was a strong
focus on a limited set of model strains that have developed
into paradigms for further applications. The early LAB
research was dominated by attention for Lactococcus lactis
due its importance as starter culture for industrial dairy
fermentations (Table 1). As the dairy lactococci contain a
large plasmid complement, plasmid-free strains were
developed and two elegantly constructed strains MG1363
and IL1403 were developed in the early 80’s [47,48]. In ret-
rospect these strains served as models for Lactococcus
lactis subsp. cremoris (MG1363) and lactis (IL1403). A
draft genome of the 2.4 Mb Lactococcus lactis IL1403 was
generated ten years ago [49] and finalized [50], whereas
that of the strain MG1363 with a slightly larger size of
2.5 Mb was reported somewhat later [51]. As MG1363 is
by far the most widely used lactococcal model strain, its
genome was recently resequenced, resulting in the correc-
tion of multiple mistakes [52]. The latter study also pro-
vided the complete genome sequence of the derivative
strain NZ9800, carrying Tn5276 and a 4-bp deletion in
the nisA gene, which is used as a host for the NICE system
[44]. These paradigm strains of Lactococcus lactis form the
basis for hundreds of genetic and metabolic studies that
have been carried out today. Remarkably, new series of
discoveries continue to be made as has recently been
shown by the presence of a pellicle polysaccharide that
covers the surface of strain MG1363 that [53].
The notion that Lactobacilli are of great importance
specifically for probiotic culture developments has greatly
stimulated their genomic characterization. The genome of
Lactobacillus plantarum was the first to be completed
and found to be among the largest genomes to date with
a size of 3.3 Mb [54]. This organism was selected as it was
a human isolate, was able to grow fast on a variety of
sugars, and was accessible to high efficiency genetic
transformation. Moreover, it had been found to efficiently
survive the intestinal tract passage making it an ideal para-
digm probiotic or delivery strain [55]. The genetic blue
print of Lactobacillus plantarum served as a basis for
rapid insight into its use in food fermentations as well as a
probiotic microbe and sparkled a wave of research interest
generating over 100 publications that are related to its
genome. The hallmark discoveries related to its genome
include the finding that the degree of alanylation of its
lipotechoic acids (LTAs) affects its immune response [56],
the notion that its survival in the human and murine host
induces over 500 genes that are not expressed in labora-
tory media [57], and the observation that its exposure in
the upper intestinal tract of human induces a marked
anti-inflammatory immune response [58]. Moreover,
Lactobacillus plantarum has served to construct the first
genome-based metabolic model generated for LAB [59]
and sparkled may other metabolic, genetic and immunolo-
gical studies that have recently been reviewed [60-62].
While Lactococcus lactis and Lactobacillus plantarum
have developed into true paradigm strains, many other
LAB are attractive candidates for model studies as they
have unique features and have large economic impact
(Table 1). A selection of these are summarized here with
attention for the genomic characterization and impact in
research and application (Table 3). Many of them are
highly transformable and this has promoted their use as
genetic model systems. It is of interest to note that there
is an inverse correlation between the presence of the
CRISPR – cas system [34] and transformability and in
retrospect it explains the relatively late discovery of this
important immunity system in LAB (Table 3). Important
probiotic paradigms are Lactobacillus acidophilus NCFM
and Lactobacillus rhamnosus GG, both of which are
worldwide used as probiotic strains [2]. Their genomes
have sparked the discovery of probiotic mechanisms,
some of which are located on special genetic elements
[Table 2]. These include the SLP-element that is affected
by induced phase variation in Lactobacillus acidophilus
NCFM and produces SlpA that mediates signaling to the
DC-SIGN receptor of dendritic cells [37]. In addition, the
genomic island ISSL1 in Lactobacillus rhamnosus GG
was found to encode the production of pili, protruding
filaments of around a micron in length that so far only
have been discovered in Gram-positive pathogens [31].
These pili were decorated with the pilus protein SpaC
that bound to human mucus, providing a molecular basis
for competitive exclusion with other mucus-binding
pathogens [[31], and unpublished observations]. It was
observed earlier that reducing the degree of alanylation,
and hence the positive charge, of LTA in Lactobacillus
plantarum affected its immune stimulation and reduced
colitis in a murine model [56]. Similarly, it was recently
reported that the complete removal of LTAs acids in
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Lactobacillus acidophilus induced its anti-inflammatory
signaling to dendritic cells and also reduced colitis in a
murine model [67]. These observations provide a mole-
cular explanation for previous findings for the in vitro
interaction between lactobacilli and the immune system.
This was recently confirmed in healthy volunteers where
a specific immune response of the upper intestinal tract
was observed following exposure to cells of Lactobacillus
plantarum[58] and other probiotic strains, including
Lactobacillus rhamnosus GG and a Lactobacillus acido-
philus strain [68]. Another seminal finding derived from
the genomic characterization of the probiotic strain
Lactobacillus salivarius UCC118 and the detection of the
coding capacity of a broad-spectrum class II bacteriocin
that inactivated Listeria monocytogenes[66] Wild-type
Lactobacillus salivarius UCC118 but not its bacteriocin-
negative mutant was found to protect mice from the
killing effect of challenges of Listeria monocytogenes,
illustrating another probiotic mechanisms [69].
With increasing technological developments and reduc-
tion of sequencing costs, more genomes were sequenced in
the last decade, including those of the yoghurt strains
Lactobacillus bulgaricus[64] and Streptococcus thermophi-
lus[65]. An important development was the comparative
analysis of nine LAB genomes in a single study, covering
wide application areas varying from dairy fermentations to
wine production [70]. Presently over 100 genomes of LAB
are deposited in public databases (Fig. 1). The majority of
these genomes have not been closed as this is notably diffi-
cult because of the presence of multiple repetitive
sequences, such as Insertion Sequences (ISs). However, as a
framework of around 25 completely closed LAB genomes is
presently available, comparative and other detailed analyses
offer new leads for functional studies as discussed below.
Comparative, pan and meta-genomics
developments
In silico comparative genomics has been applied ever
since the first complete genomes of the same genus
were reported and included those of Lactobacillus plan-
tarum and Lactobacillus johnsonii[71]. However, these
genomes differ in size by about 1 Mb and limited con-
servation was observed [72]. On a larger scale, compara-
tive genomics was applied to explain the origin of LAB
based on a set of a dozen different LAB genomes [70].
An evolutionary tree of LAB could be generated that
explained the present LAB genomes by a series of multi-
ple gene losses and acquisitions. This important concept
also indicated that LAB and Bacillus subtilis shared a
common ancestor, providing a teleological explanation
for the success of many genetic tools that have been
developed for Bacillus systems and work efficiently in
LAB and vice versa. The recent observation that Strepto-
coccus thermophilus and possibly other LAB may
become competent and hence are naturally transform-
able provides another practically important example
[73]. Natural transformation in conjunction with other
mutation selection systems would provide an important
tool to expand the genetic potential of LAB without
them being labeled as GMO.
Most of the LAB genomes contain around 2000-3000
genes. The question arises how different these genes are
and whether a core genome can be found. Comparative
analysis of 20 completely sequenced Lactobacillus gen-
omes showed the pan genome to contain approximately
14000 genes and indicated the presence of a core genome
of 383 orthologous genes [74]. These and other compara-
tive studies confirmed the fact that about one third of the
pan genome can not be accurately annotated and that
there exists series of wrongly or poorly annotated genes.
In silico comparative genomics approaches can address
those and together with experimental analyses lead to
improved annotations and discovery of new functions.
The first of these were performed by comparative gen-
ome hybridization using a microarray of Lactobacillus
plantarum WCFS1 that was tested with DNA of a dozen
of related strains from different habitats [75]. The results
indicated the presence of specific genomic regions, called
Table 3 Paradigm strains of LAB. A listing of the most relevant LAB strains, their genome size and year of publication
is provided. Moreover, the presence of CRISPR sequences is given with a summary of the reported transformation
frequency, varying from very high, high, medium to low, representing 106-108, 104-106, 102-104, 100-102
transformants per ug of DNA, respectively. ND, indicates not determined
Paradigms Strains Genome Size Publication Year Transformation CRISPR References
Lactococcus lactis IL1403 2.4 Mb 2001 very high none [50]
Lactococcus lactis MG1361 2.5 Mb 2007 very high none [51]
Lactobacillus plantarum WCFS1 3.3 Mb 2003 very high none [54]
Lactobacillus acidophilus NCFM 2.0 Mb 2005 high none [63]
Lactobacillus rhamnosus GG 3.3 Mb 2009 medium yes [31]
Lactobacillus salivarius UCC118 2.0 Mb 2006 medium yes [64]
Lactobacillus bulgaricus 1.9 Mb 2006 low yes [65]
Streptococcus thermophilus 2.0 Mb 2004 medium yes [66]
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life-style islands that were already predicted from the
genome with unusual G+C content and varied between
the different strains [54]. Moreover, gene-trait matching
was performed and this led to the discovery of a man-
nose-binding protein encoding gene that is present in
probiotic strains of Lactobacillus plantarum and may
contribute to competitive exclusion with pathogenic
Escherichia coli strains that are known to bind to man-
nose [76]. Various other comparative genomic studies
capitalized on large strain collections and advanced
bioinformatic tools developed to allow for rapid gene-
trait matching [77]. Recently, this led to the assignment
of a series of candidate genes involved in immunological
signaling [78]. The advantage of comparative genome
hybridization is that use is made of the natural biodiver-
sity of LAB and rapid molecular insight is generated.
From an applied perspective this is highly desired as it is
a non-GMO approach. However, as all comparisons are
realized by using an array of a single strain, no insight in
any new coding sequences is generated and this can only
be realized by sequence analysis and in silico
comparisons.
Advanced comparative genomics and metagenomics
approaches can nowadays be realized by deep sequence
analysis using Next Generation Technology (NGT)
sequencing approaches. The first LAB genome that was
completed using NGT sequencing was that of Lactobacil-
lus rhamnosus GG and all following ones have been based
on some form of NGT sequencing. In addition, deep rese-
quencing has been realized that generated the genome
sequence of the well-known strain NZ9000 used as host
for the NICE system [44] and this also allowed for correct-
ing sequence errors in the genome of its parent MG1363
[52]. Moreover, draft genome sequences that are almost
full length have been generated as is illustrated by the
genomic sequencing of a dozen of Lactobacillus strains as
part of the Human Microbiome Project [79]. The use of
NGT sequencing approaches explains the rapid boost in
the number of LAB genomes deposited in public databases
in recent years [Fig. 1]. To exemplify the rapid analysis, we
determined recently draft genomic sequences of approxi-
mately 100 strains of Lactobacillus rhamnosus-like strains
obtained from food, clinical and other environmental
samples using NGT approaches [WMdV, unpublished
observations].
Next to advanced comparative genomics also metage-
nomic approaches are being applied using NGT sequen-
cing and these are specifically suitable for the analysis of
mixed cultures. The practical importance of mixed strain
starters is enormous as cultures of LAB consisting of mul-
tiple strains of undefined composition are widely used in
the dairy and other food industries. In many cases these
mixed strain starters are used intentionally to increase the
diversity, and hence resilience and robustness. In other
cases, mixed cultures are used unintentionally and relate
to the heterogeneity that originates when strains of LAB
are repeatedly subcultured [80]. Many mixed cultures also
contain bacteriophages that contribute to the equilibrium
between the strains, as has been illustrated for the phage–
carrying situation [81]. Such mixed starter cultures can be
seen as developing ecosystems. Hence, the application of
NGT sequencing approaches to describe its collective
metagenome will be instrumental in understanding the
behavior of these mixed cultures and explaining as well as
predicting their success in industrial fermentations.
High throughput developments – functional
analysis and screening
One of the great achievements of the omics revolution is
the development of high throughput functional genomics
approaches. Notably transcriptomics studies have been
instrumental in analyzing the response of LAB to different
environments and over 100 papers have been published
addressing a variety of stresses, growth conditions and cul-
turing regimens. Among the most important practical dis-
coveries was the finding that Lactococcus lactis and other
LAB, when provided with the appropriate cofactors, such
as heme, could use alternative electron acceptors and
hence respire rather than ferment [82]. Following the first
description of the use of molecular oxygen by Lactococcus
lactis MG1363 [83], a variety of studies have followed that
have been reviewed recently [84]. Transcriptional studies
allowed to identify the genes involved in the use of mole-
cular oxygen that resulted in a wide range of applications,
notably faster growth and higher yield of starter cultures
[85]. Biochemical studies confirmed that indeed a proton
motive force was generated during respiration illustrating
the link between transcriptional and functional studies
[86]. Moreover, some LAB also were found to use nitrate
as terminal electron acceptor, expanding further the possi-
bilities beyond fermentation [87].
Analysis of the transcriptional response is a powerful
tool to study fast responses. The analysis of the response
to acid stress was the first microarray study reported and
related to Lactobacillus plantarum[88]. Subsequently, a
large set of hundreds of transcriptional responses have
been collected that have been systematically addressed by
advanced correlation analysis using newly developed tools
[89]. This helped to find a series of supergenomic net-
works and provided further insight in global regulation
systems as recently reported [89]. Moreover, the use of
metabolic maps based on the genome-based modeling
[59] permitted rapid display and analysis of the expressed
genes and in such a way it was found that during aerobic
growth of Lactobacillus plantarum, carbon dioxide was
required to allow rapid and uninterrupted growth [90].
Another important observation made by using a com-
munity transcriptomics approach was the finding that
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the human isolate Lactobacillus plantarum expressed a
completely different set of genes in the intestine as com-
pared to growth in laboratory media [57]. This partly
explained the large coding capacity of over 3000 genes
of this human isolate. Remarkably, a highly comparable
expression profile in mice and human was generated,
indicating similarities in the intestinal adaptation [57].
Due to the high signal to noise ratio of the microarrays,
this analysis could be performed in the complex intest-
inal ecosystem where LAB represent a fraction of the
total number of cells. More advanced metatranscrip-
tomics studies that also capitalize on this property pro-
vided by microarrays aim to analyze the transcriptional
response in complex food ecosystems. This requires
microarrays of multiple strains and the feasibility can be
exemplified with the consortium of Lactobacillus bulgar-
icus and Streptococcus thermophilus that is involved in
yoghurt fermentation [91]. Parallel global transcriptome
analysis of the consortium during growth in milk pro-
vided evidence for the involvement of specific com-
pounds and metabolic pathways in the interactions
between the two strains [91,92]. This is one of the few
studies that is performed in an industrial environment
and the generated insight may be extrapolated to design
stable interactions of other consortia of interacting
strains, including probiotics.
It is known from earlier studies that characteristic LAB
communities are developing in fermented foods such as
cheese [93]. Microarrays representing multiple LAB gen-
omes have been used to determine the response during
these successions. Insight in the biodiversity and activity
was generated for the fermentation of kimchi, a traditional
Korean vegetable product, described to contain various
health-promoting factors [94]. Similar approaches were
recently applied to complex and uncontrolled sour dough
fermentations [95]. These examples all relate to fermenta-
tions of plant-derived products and it may be expected
that use of these approaches will also be instrumental in
analyzing the events in industrial dairy fermentations with
complex cultures. Presently, NGT sequencing is being
applied to determine global transcriptional responses and
this holds great potential as the sequence depth is increas-
ing steadily [96]. These approaches are specifically useful
to address small RNAs and their processing, possibly non-
coding regions, and LAB communities that have not yet
been characterized completely.
Proteomics studies have been instrumental in identifying
adaptations that take place over a longer time frame than
transcriptomics responses. In a recent systematic study the
proteomic and transcriptional responses of the probiotic
Lactobacillus rhamnosus GG to bile acid were compared
[97]. Both approaches were complementary to each other
and pointed towards the reduction in EPS production fol-
lowing exposure to bile acid, suggestion that in the
intestinal tract cell-envelope located proteins, such as
anchored by the action of sortases, are exposed to the
extracellular environment. This provided the basis for
new probiotic mechanisms to be analyzed Lactobacillus
rhamnosus GG, such as the exposure of the mucus
binding protein or the effect of pili in reducing the IL-8
stimulation by lipotechoic acids in human enterocytes that
both are more pronounced in EPS-deficient cells [98].
While analysis of relevant metabolites is standard phy-
siological practice, global metabolomics studies have not
been reported frequently for LAB, which may be explained
by the complex set of biochemical instruments needed for
high throughput metabolic analyses. However, a recent
comparative metabolomics and transcriptomics analysis of
folate-overproducing Lactobacillus plantarum cells was
reported to explain its reducing effect on the growth rate
[99] . Remarkably, only little effect on the transcriptome
and metabolome was observed but the great impact on
the growth rate was explained by the gratuitous produc-
tion of large amounts of folate-related transcripts and
proteins.
The usefulness of transcriptomics, proteomics and
metabolomics studies depend largely on the stability of
the detected molecules. This is not the case with systems
that can operate along all time scales and can be detected
infinitely as they concern permanent genetic changes.
This holds for the in vitro expression technology (IVET)
approaches and variations thereof. These are high
throughput systems that capitalize on upregulation of
gene expression and need efficient transformation sys-
tems or intermediary hosts. The first IVET studies in
LAB were performed in Lactobacillus plantarum and
revealed genes that were upregulated in the murine host
[100]. These pioneering studies required the optimization
of tools that were later used in IVET studies addressing
the response of Lactococcus lactis cultures in the cheese
production process. This is a highly relevant approach
and this study revealed a series of genes involved in the
cheese maturation process [101]. A great variety of efforts
focusing on reducing cheese maturation times have been
reported, the most advanced being the use of cell density
induced lysis of lactococcal cells [46]. However, there is a
great need to extend beyond that knowledge and develop
systems that are based on the natural induced genes as
have now been exposed using the IVET approach.
In general, omics and the other described high
throughput approaches generate leads that form the basis
for functional genomics approaches. The throughput of
these functional studies is often a bottleneck but has
been greatly improved by efficient transformation and
expression platforms (see above) as well as systems for
generating rapidly multiple mutations in a single strain.
An efficient cre-lox system for obtaining such multiple
mutants in an efficient and successive way have been
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described for Lactobacillus plantarum that may be con-
sidered as self-cloning [102]. On the practical side also
high throughput developments have been reported and
an ingenious system of small cheeses has been designed
and used [103]. Finally, a variety of in vitro systems that
may predict practical conditions have been reported,
such as the use of non-growing cells of Lactococcus lactis
strains for the rapid analysis of flavor production [104].
To avoid all GMO related issues, the best optimization
of industrial LAB is to generate mutants. While the use of
advanced genetic systems, such as mutator strains, has
been described [105], natural means of creating diversity
are also feasible and may be sufficiently frequent to gener-
ate variation that subsequently can be selected. This has
been shown for the adaptive evolution of Lactococcus lac-
tis for over 1000 generations that revealed the mobility
and subsequent mutation by IS elements [106]. It is well
known that IS elements are a powerful source of generat-
ing variation as has been illustrated for the construction of
lactose-deficient mutants to prevent post-fermentation
acidification in Lactobacillus bulgaricus[107]. Another
dimension has been generated by all kinds of high
throughput equipment and is supported by whole genome
NGT resequencing to provide insight in the nature of the
generated mutations. This has been tested in the adaptive
evolution of yoghurt strains that had not previously been
grown together in a consortium. It was found that more
than 1000 generations of growth resulted in stable consor-
tia of naïve strains of Lactobacillus bulgaricus and Strepto-
coccus thermophilus that even outperformed industrial
consortia for growth rate [92]. Whole genome re-sequen-
cing detected multiple mutations in both species that
affected metabolic pathways relating to their interdepen-
dence. These results illustrate the need for an advanced
understanding of the metabolic network relations that can
be exploited to generate stable consortia of LAB consisting
of fermentative or probiotic strains.
Systems and synthetic biology – integrating
metabolism, genetics & application
To capture the full potential of the omics and other high
throughput development, a systems biology approach is
essential [108]. Basically, this allows incorporating experi-
mental data into an intellectual framework of a model and
hence integrate these into a hypothesis generating system.
In the full circle of the systems biology, the generated
hypothesis can be tested experimentally, optimizing and
extending the models. The power of this approach can be
illustrated by examples of the advances made in Lactobacil-
lus plantarum as reviewed recently [60]. Based on the
Lactobacillus plantarum genome, a metabolic model was
created that described very well the growth and product
formation when grown in minimal media on glucose [59].
What the flux balance analysis model also predicted was
that Lactobacillus plantarum strain not only should grow
efficiently on hexose sugars but also on glycerol, a C3 com-
pound. However, the wild-type strain showed only a very
low growth rate on glycerol, indicating the presence of an
unexpected bottleneck. By adaptive evolution supported by
efficient growth using oxygen as electron acceptor, a deri-
vative strain of Lactobacillus plantarum was obtained that
completely converted glycerol into mainly lactic acid as
predicted by the genome-based model [109]. In this sys-
tems biology approach, the experimental data provided
further insight as genomic resequencing of the resultant
strain showed promoter mutations and relieve of catabolite
repression of the glycerol operon [E.J. Smid, personal com-
munication]. The inability to predict this bottleneck among
others results from the absence of hierarchal control data
in the metabolic model and their incorporation would
provide the next level of sophistication.
It is evident that systems biology approaches capitalize
on genomic information, genome based modeling and
high throughput experimentation. As it aims to generate
productive outcomes, as such it integrates genetics, meta-
bolism and applications. Moreover, systems biology can
capture previous knowledge and this even increases its
power [108]. Hence, the paradigm LAB are ideal organ-
isms to further exploit using systems biology approaches.
Notably for Lactococcus lactis a large body of information
has been collected, including a variety of kinetic, static
and genome-based models that have been reviewed
[109,110]. However, new and refined models are continu-
ously emerging testifying for the interest in the systems
biology approach and this paradigm LAB strain
[112-114]. Moreover, a wealth of metabolic data is avail-
able for Lactococcus lactis MG1363 as it has been used in
a multitude of metabolic engineering experiments [115].
Many of these have been highly successful and these are
summarized here since under optimal conditions the flux
distribution reaches the theoretical maximum (Table 4).
These extreme fluxes are highly unusual and affirm the
usefulness of Lactococcus lactis as a host for metabolic
engineering in which growth and production can be
uncoupled [115]. Various factors may contribute to this,
including its simple metabolism, limited redundancy and
few high level control systems in its small genome. Its
relative simplicity was confirmed by comparative model-
ing studies where genome-based models and transcrip-
tional responses of Lactococus lactis, Lactobacillus
plantarum and Streptococus thermophilus were com-
pared [119]. A last level of sophistication in the modeling
approach is the construction of models for mixed cul-
tures. This has been realized for the yoghurt consortium
consisting of Streptococcus thermophilus and Lactobacil-
lus bulgaricus and provided important support for the
explanation of experimental data [92]. Further modeling
of more complex consortia of LAB such as in mixed
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cultures is also feasible and bottom-up as well as top-
down approaches to realize this have been recently
reviewed [120].
The unusual success of metabolic engineering
approaches in Lactococcus lactis [Table 4] together with
its high transformation efficiency [Table 2] indicates
that this and possibly other LAB are promising candi-
dates for synthetic biology applications. Synthetic DNA
was rapidly incorporated in the genetic engineering of
LAB and was already 20 years ago used to optimize con-
structs from Lactococcus lactis expression [121]. In addi-
tion, some of the first synthetic promoters were
designed for Lactococcus lactis[122]. However, the pre-
sent developments in synthetic biology not only allow
gene fragments, cassettes or operons to be synthesized
but even complete genomes [123]. While there are
many bottlenecks, varying from modeling multiple gene
functions to booting up new genomes, synthetic biology
is the ultimate engineering approach that capitalizes
upon a real biological understanding. By exploiting
designed DNA up to the size of a complete genome,
synthetic biology builds upon the systems biology
approaches that have been discussed above.
What synthetic biology approaches could be applied to
LAB ? One avenue is to build upon functions that are pre-
sent and can be optimized, given the profound knowledge
of their biology. This can include the production of high
value ingredients such as vitamin B12 produced by Lacto-
bacillus reuteri[124], specific flavors from amino acids as
synthesized by Lactococcus lactis or Streptococcus thermo-
philus[119], or the production of plant-stimulating com-
pounds that can be produced by Lactobacillus plantarum
at zero-growth conditions [125]. Similarly, one can think
of new anti-infectives based on the large potential of LAB
in the production of bacteriocins or lantibiotics, such as
nisin [127]. However, these are all products that are rather
traditional. More exciting are new products or strains.
One possibility is to generate biobricks of probiotic gene
functions [[128]; Table 2] that can be incorporated in dif-
ferent hosts and, in varying combinations, tested in high
throughput systems for functionality. Similarly, new LAB
vaccine strains could be developed where large synthetic
DNA fragments are employed. Significant developments
have emerged since the first description of lactoccci as
oral vaccines [128,62] and specific helper functions that
boost the antigenic response have recently been discovered
[129]. A final option is to further capitalize on the physio-
logical strengths of LAB. These include their high stress
resistance, tolerance to low pH, and uncoupling of growth
and production. This can be linked to high growth rates,
sometimes at elevated temperatures, and the use of both
hexoses and C5 sugars, while redox balancing can be rea-
lized in several ways by respiration [82,84] or the use of
water-forming NADH oxidases as demonstrated pre-
viously [130]. There are great opportunities, including the
production of organic acids other than lactic acid, such as
succinic acid, malic acid or propionic acid. Moreover,
many LAB have a high level of alcohol tolerance and are
even observed as contaminants of commercial alcohol pro-
duction [131]. Hence, the possibilities of producing buta-
nol, isobutanol or higher alcohols can be considered and
several engineering efforts towards generating these pro-
ducts have already been reported [132,133]. However, in
order to be competitive with present white biotechnology
production systems, the LAB hosts should be optimized
for prototrophic growth on simple media obviating the
need for yeast extract or other additions. With the present
metabolic models in combination with synthetic biology
approaches this should be feasible and then we would be
entering into a new era where exciting new developments
are to be expected.
Conclusions
The genomic characterization of LAB has rocketed and
presently over 25 complete and 100 or so nearly com-
plete genomes are available. Many of these derive from
strains that serve as scientific paradigms and have
reached the market place as the industrial use of LAB is
worth over a 100 Billion Euro per year. Several paradigm
LAB have been presented here with their most salient
features that include genome based modeling as well as
systems and synthetic biology approaches. The field of
LAB is developing really rapidly and an impressive set of
discoveries have been made that had not been anticipated
ten years ago [134]. When considering the large amount
of knowledge available, the logic step is to further
improve existing products and start developing NGT
products for food, pharma and white biotechnology. It is
an expectation and desire that this review contributes to
these exciting new developments by inspiring new scien-
tific talents to do so.
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Table 4 Selected metabolic engineering studies with
Lactococcus lactis MG1363. The new product, its
properties and the efficiency of the flux redistribution
from glucose
Product Functional Properties Flux Reference
Alanine Flavor, L-Amino Acid > 99 [116]
a-Acetolactate Flavor, Precursor ~ 70 [117]
Aceetaldehyde Flavor, Conservation ~ 50 [118]
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